Publication

Targeted Gene Sequencing in Children with Crohn's Disease and Their Parents: Implications for Missing Heritability

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Jiun-Sheng Chen, The University of Texas MD Anderson Cancer CenterFulan Hu, The University of Texas MD Anderson Cancer CenterSubra Kugathasan, Emory UniversityLynn B. Jorde, University of UtahDavid Nix, University of UtahAnn Rutherford, University of UtahLee Denson, Cincinnati Children’s Hospital Medical CenterW. Scott Watkins, University of UtahSampath Prahalad, Emory UniversityChad Huff, The University of Texas MD Anderson Cancer CenterStephen L. Guthery, University of Utah
Language
  • English
Date
  • 2018-09-01
Publisher
  • Genetics Society of America: G3
Publication Version
Copyright Statement
  • © 2018 Chen et al.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 2160-1836
Volume
  • 8
Issue
  • 9
Start Page
  • 2881
End Page
  • 2888
Grant/Funding Information
  • The research reported in this publication was supported (in part or in full) by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001067.
  • This work was funded by DK091374, GM104390, and GM118335 from the National Institutes of Health.
Abstract
  • Crohn's disease is a complex genetic trait characterized by chronic relapsing intestinal inflammation. Genome wide association studies (GWAS) have identified more than 170 loci associated with the disease, accounting for ~14% of the disease variance. We hypothesized that rare genetic variation in GWAS positional candidates also contribute to disease pathogenesis. We performed targeted, massively-parallel sequencing of 101 genes in 205 children with Crohn's disease, including 179 parent-child trios and 200 controls, both of European ancestry.We used the gene burden test implemented in VAAST and estimated effect sizes using logistic regression and meta-analyses. We identified three genes with nominally significant p-values: NOD2, RTKN2, and MGAT3. Only NOD2 was significant after correcting for multiple comparisons. We identified eight novel rare variants in NOD2 that are likely disease-associated. Incorporation of rare variation and compound heterozygosity nominally increased the proportion of variance explained from 0.074 to 0.089. We estimated the population attributable risk and total heritability of variation in NOD2 to be 32.9% and 3.4%, respectively, with 3.7% and 0.25% accounted for by rare putatively functional variants. Sequencing probands (as opposed to genotyping) to identify rare variants and incorporating phase by sequencing parents can recover a portion of the missing heritability of Crohn's disease.
Author Notes
  • Corresponding authors: Chad Huff, 1155 Pressler St, Houston, TX 77030, Phone: 713- 563-4957, E-mail: CHuff1@mdanderson.org; Stephen L. Guthery, 81 N Mario Capecchi Drive, Salt Lake City, UT 84113, Phone: 801-213-3599, E-mail: Stephen. Guthery@hsc.utah.edu
Keywords
Research Categories
  • Health Sciences, Epidemiology
  • Biology, Biostatistics
  • Biology, Genetics

Tools

Relations

In Collection:

Items